Home » Topics » Regulatory

Regulatory
RSS

Ziprasidone pharmaceutical formulations with good solubility properties

Nov. 30, 2000

FDA approves Lovenox for seventh indication

Nov. 22, 2000

FDA approves Boehringer Ingelheim's Micardis HCT

Nov. 21, 2000

New Tamiflu indication for prevention of influenza approved by FDA

Nov. 21, 2000

E.C. approves Roche's CellCept for prevention of liver transplant rejection

Nov. 20, 2000

Steroid-free eczema treatment recommended for FDA approval

Nov. 17, 2000

Lilly's Zyprexa approved by FDA for extended schizophrenia indication

Nov. 15, 2000

Abbott submits Biaxin XL sNDA for CAP

Nov. 14, 2000

Pariet receives E.U. approval for H. pylori eradication in peptic ulcer disease

Nov. 14, 2000

Astelin Nasal Spray approved in U.S. for treatment of nonallergic vasomotor rhinitis

Nov. 10, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...
Circulating sncRNA transcriptome in diabetic kidney disease and SGLT2 inhibitor treatment
BioWorld Science
Small noncoding RNAs (sncRNAs), including miRNAs, piRNAs and snoRNAs, can provide further biological insights into the mechanisms of chronic kidney disease (CKD)...